ACM Research, Inc.
ACMR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.92 | 0.30 | -0.50 | 3.74 |
| FCF Yield | -0.59% | -3.62% | -0.80% | 7.98% |
| EV / EBITDA | 29.75 | 34.47 | 39.59 | 12.05 |
| Quality | ||||
| ROIC | 1.28% | 2.02% | 1.69% | 2.36% |
| Gross Margin | 42.04% | 48.50% | 47.90% | 49.59% |
| Cash Conversion Ratio | -0.10 | -1.24 | 0.21 | 2.27 |
| Growth | ||||
| Revenue 3-Year CAGR | 21.08% | 20.92% | 23.99% | 26.23% |
| Free Cash Flow Growth | 75.26% | -408.01% | -115.62% | 452.75% |
| Safety | ||||
| Net Debt / EBITDA | -19.71 | -3.83 | -6.93 | -3.61 |
| Interest Coverage | 15.63 | 18.04 | 16.54 | 35.82 |
| Efficiency | ||||
| Inventory Turnover | 0.23 | 0.17 | 0.15 | 0.19 |
| Cash Conversion Cycle | 448.77 | 588.72 | 715.08 | 539.18 |